Billable / Specific Code
ICD-10-CM Z19.2 is the diagnosis code for Hormone resistant malignancy status. This code falls under the section "Hormone sensitivity malignancy status" within Chapter 21 — Factors influencing health status and contact with health services (Z00-Z99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where Z19.2 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, Z19.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Z19.2 is the ICD-10-CM diagnosis code for "Hormone resistant malignancy status". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of Z19.2 is Z19 ("Hormone sensitivity malignancy status"). Z19.2 provides a more specific classification within this category.
Z19.2 is located in Section Z19 — "Hormone sensitivity malignancy status" within Chapter 21 of the ICD-10-CM Tabular List.
Use Z19.2 when the patients documented diagnosis matches "Hormone resistant malignancy status" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Hormone resistant malignancy status is Z19.2.
Yes, Z19.2 can be used as a primary diagnosis code since it is billable and specific.
Z19.2 is in Chapter 21 of the ICD-10-CM Tabular List.
Yes, Z19.2 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.